Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

GHSI

Guardion Health Sciences Inc

Apr 19 • 02:54PM ET

8.01

Dollar change -0.04
Percentage change -0.56	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	66.05	EPS (ttm)	0.12	Insider Own	20.06%	Shs Outstand	1.28M	Perf Week	1.33%
Market Cap	10.25M	Forward P/E	-	EPS next Y	-1.02	Insider Trans	0.00%	Shs Float	1.03M	Perf Month	-11.15%
Income	0.16M	PEG	-	EPS next Q	-0.88	Inst Own	17.51%	Short Float	13.57%	Perf Quarter	53.35%
Sales	12.25M	P/S	0.84	EPS this Y	-2100.00%	Inst Trans	-	Short Ratio	0.64	Perf Half Y	14.20%
Book/sh	6.39	P/B	1.25	EPS next Y	57.50%	ROA	0.94%	Short Interest	0.14M	Perf Year	44.11%
Cash/sh	4.97	P/C	1.61	EPS next 5Y	-	ROE	1.48%	52W Range	5.01 - 10.75	Perf YTD	49.91%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	1.94%	52W High	-25.53%	Beta	0.90
Dividend TTM	-	Quick Ratio	6.98	Sales past 5Y	90.30%	Gross Margin	43.92%	52W Low	59.78%	ATR (14)	0.33
Dividend Ex-Date	-	Current Ratio	9.01	EPS Y/Y TTM	100.87%	Oper. Margin	-32.18%	RSI (14)	42.97	Volatility	1.95% 3.09%
Employees	9	Debt/Eq	0.00	Sales Y/Y TTM	10.85%	Profit Margin	1.29%	Recom	3.00	Target Price	12.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	104.29%	Payout	0.00%	Rel Volume	0.03	Prev Close	8.05
Sales Surprise	0.00%	EPS Surprise	0.00%	Sales Q/Q	7.68%	Earnings	Mar 29 BMO	Avg Volume	219.93K	Price	8.01
SMA20	-6.75%	SMA50	-4.57%	SMA200	11.82%	Trades		Volume	5,321	Change	-0.56%

Mar-29-24 06:15AM	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 (GlobeNewswire)
Jan-31-24 10:54AM	Why Is Guardion Health (GHSI) Stock Up 66% Today? (InvestorPlace) +62.72%
Jan-30-24 06:13PM	Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv Brand and Business to Doctor's Best Inc. (GlobeNewswire)
Nov-13-23 04:10PM	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 (GlobeNewswire) -9.57%
Aug-14-23 08:15AM	Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 (GlobeNewswire)
08:00AM	Loading…
May-30-23 08:00AM	Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer (GlobeNewswire) -6.60%
May-15-23 08:15AM	Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
Apr-17-23 08:15AM	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 (GlobeNewswire) +7.30%
Mar-06-23 08:00AM	Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value (GlobeNewswire)
Jan-24-23 04:05PM	Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements (GlobeNewswire)
Jan-12-23 06:50AM	Daily Vickers Top Buyers & Sellers for 01/12/2023 (Argus Research) +10.10%
Jan-06-23 04:15PM	Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023 (GlobeNewswire) -15.97%
Nov-29-22 05:06PM	Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock (GlobeNewswire)
Nov-14-22 08:25AM	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022 (GlobeNewswire) -8.76%
Oct-06-22 08:00AM	Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost Gel Bites Increase Omega-3 Levels in Just 4 weeks (GlobeNewswire) +31.01%
08:20AM	Loading…
Aug-11-22 08:20AM	Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire) +12.53%
Jun-09-22 09:00AM	ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardions Upcoming 2022 Annual Stockholders Meeting (GlobeNewswire) -5.23%
Jun-01-22 08:38AM	Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories (GlobeNewswire)
May-26-22 09:00AM	Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon (GlobeNewswire) +37.00%
May-12-22 08:13AM	Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire)
May-03-22 03:45PM	Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022 (GlobeNewswire)
Apr-27-22 09:00AM	Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV (ACCESSWIRE) +6.12%
Apr-11-22 09:17AM	Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store (GlobeNewswire)
Apr-01-22 09:03AM	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021 (GlobeNewswire) -7.51%
Mar-11-22 08:00AM	Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference (GlobeNewswire)
Feb-23-22 04:15PM	Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering (GlobeNewswire) -7.68%
Feb-18-22 09:00AM	Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering (GlobeNewswire) -45.73%
Feb-17-22 09:00AM	Guardion Health Sciences, Inc. Announces Proposed Public Offering (GlobeNewswire) -34.12%
Feb-14-22 08:00AM	Guardion Health Sciences Launches New Viactiv® Omega BOOST Passion Fruit Flavored Gel Bites (GlobeNewswire)
Jan-24-22 08:30AM	Guardion Health Sciences Launches New Online Store for Viactiv (GlobeNewswire)
08:00AM	Loading…
Jan-06-22 08:00AM	Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference (GlobeNewswire)
Dec-23-21 04:05PM	Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property (GlobeNewswire)
Dec-16-21 08:00AM	Guardion Health Sciences Issues Letter to Shareholders (GlobeNewswire)
Dec-09-21 08:30AM	Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs to its Board of Directors (GlobeNewswire)
Dec-03-21 08:00AM	Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference (GlobeNewswire) -8.34%
Nov-10-21 08:37AM	Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021 (GlobeNewswire) -5.11%
Oct-25-21 08:00AM	Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference (GlobeNewswire)
Oct-14-21 08:00AM	Guardion Health Sciences Announces Corporate Milestones Designed to Strengthen Financial Results and Improve Customer and Investor Engagement (GlobeNewswire)
Oct-12-21 10:30AM	Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting (GlobeNewswire)
Oct-05-21 08:00AM	Guardion Health Sciences to Present at the LD Micro Main Event Conference (GlobeNewswire)
Sep-27-21 09:15AM	Guardion Health Sciences to Present at the Benzinga Healthcare Small Cap Conference (GlobeNewswire)
Sep-09-21 08:30AM	Guardion Health Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference (GlobeNewswire)
Aug-16-21 08:15AM	Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardions Ownership (GlobeNewswire)
Jul-22-21 04:15PM	Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Jun-14-21 08:05AM	Guardion Health Sciences to Be Added to the Russell 3000 Index (GlobeNewswire)
Jun-03-21 08:17AM	Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer (GlobeNewswire)
Jun-02-21 09:07AM	Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals (GlobeNewswire)
08:03AM	Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 (GlobeNewswire)
May-18-21 09:25AM	Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc. (GlobeNewswire) +12.10%
May-17-21 04:05PM	Guardion Health Sciences Announces Financial Results for the Three Months Ended March 31, 2021 (GlobeNewswire)
May-03-21 08:10AM	Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product (GlobeNewswire)
Mar-26-21 08:00AM	Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020 (GlobeNewswire)
Mar-16-21 08:00AM	Guardion Health Sciences Regains Compliance with Nasdaq Minimum Bid Price Rule (GlobeNewswire)
Mar-11-21 08:00AM	Guardion Health Sciences to Participate in Maxim Groups Inaugural Emerging Growth Virtual Conference (GlobeNewswire) +15.14%
Feb-26-21 08:57AM	Guardion Health stock tumbles after reverse stock split announcement (MarketWatch) -27.36%
08:00AM	Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021 (GlobeNewswire)
Jan-28-21 04:15PM	Malaysias Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences (GlobeNewswire) +16.48%
Jan-27-21 08:30AM	Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule (GlobeNewswire)
Jan-07-21 01:46AM	Should Guardion Health Sciences (NASDAQ:GHSI) Be Disappointed With Their 94% Profit? (Simply Wall St.) +6.19%
Dec-28-20 04:20PM	Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer (GlobeNewswire) -8.36%
Dec-16-20 08:00AM	Guardion Health Sciences Announces Development of New Vision/Energy Support Drink EPIQ-V (GlobeNewswire)
Nov-12-20 04:05PM	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020 (GlobeNewswire) -6.72%
Oct-28-20 08:30AM	Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardions Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation (GlobeNewswire)
Oct-27-20 08:30AM	Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders Meeting (GlobeNewswire) -16.72%
Oct-26-20 08:00AM	Guardion Health Sciences Announces Investigator-Initiated Clinical Trial of Lumega-Z (GlobeNewswire) +10.40%
Oct-05-20 09:15AM	We Think Guardion Health Sciences (NASDAQ:GHSI) Needs To Drive Business Growth Carefully (Simply Wall St.)
08:30AM	Guardion Provides Update on Strategy, Business Plans and Initiatives (GlobeNewswire)
Sep-11-20 05:20PM	Guardion Announces Virtual Annual Meeting of Stockholders (GlobeNewswire) -8.09%
Aug-27-20 08:30AM	Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support Supplement (GlobeNewswire)
Aug-12-20 04:05PM	Guardion Health Sciences Reports Results of Operations for Quarter Ended June 30, 2020 (GlobeNewswire)
Aug-06-20 04:05PM	Guardion Health Sciences to Report Second Quarter 2020 Financial Results on August 12, 2020 (GlobeNewswire)
Jul-21-20 08:30AM	Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management Team (GlobeNewswire)
Jul-15-20 09:00AM	Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark (GlobeNewswire)
Jul-08-20 08:45AM	Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease (GlobeNewswire)
Jun-30-20 05:00AM	Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer (GlobeNewswire)
Jun-15-20 04:20PM	Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer (GlobeNewswire) +12.93%
May-14-20 07:00AM	Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update (GlobeNewswire) -6.83%
May-12-20 07:05AM	Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density (GlobeNewswire)
Apr-15-20 09:05AM	Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit (GlobeNewswire) -11.16%
Apr-14-20 11:00AM	Guardion Health Sciences Announces Launch of acuMMUNE: An Immuno-Supportive/Anti-Oxidant Complex (GlobeNewswire)
Apr-01-20 07:00AM	Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula (GlobeNewswire) -6.62%
Mar-30-20 09:00AM	Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview (GlobeNewswire) -7.09%
Mar-19-20 12:05PM	Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule (GlobeNewswire)
Mar-06-20 08:05AM	Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants (GlobeNewswire)
Feb-26-20 07:00AM	Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula (GlobeNewswire)
Feb-06-20 07:00AM	Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections (GlobeNewswire) +13.93%
Jan-07-20 11:02AM	Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line (GlobeNewswire) -8.11%
Nov-14-19 07:00AM	Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019 (GlobeNewswire) -8.52%
Oct-30-19 12:33PM	Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering (GlobeNewswire)
Oct-28-19 09:21AM	Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering (GlobeNewswire) -34.80%
Oct-23-19 07:00AM	Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF (GlobeNewswire)
Oct-17-19 10:40AM	Here's Why We're A Bit Worried About Guardion Health Sciences's (NASDAQ:GHSI) Cash Burn Situation (Simply Wall St.)
Oct-10-19 10:30AM	Guardion® Announces Statistically Significant Blood Assay Study Results (GlobeNewswire) +5.10%
Sep-23-19 10:30AM	Guardion Health Sciences Acquires the NutriGuard Brand of Products (GlobeNewswire) +20.13%
Sep-03-19 02:08PM	Best & worst performing IPOs in 2019 (Yahoo Finance Video)
07:00AM	Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test (GlobeNewswire)
Aug-15-19 04:05PM	Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering (GlobeNewswire)
08:35AM	Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering (GlobeNewswire)
Aug-13-19 09:00AM	Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering (GlobeNewswire) -59.66%
Aug-12-19 08:40AM	Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations (GlobeNewswire) -8.49%

Guardion Health Sciences, Inc. engages in the development and distribution of clinically supported dietary supplements and medical foods. The firm also offers science-based products and devices designed to support healthcare professionals, providers, patients, and consumers. The company was founded by Michael Favish in December 2009 and is headquartered in Houston, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GHSI

Guardion Health Sciences Inc

Upgrade your FINVIZ experience